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Background: Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality 
throughout the world and is the only major disease that is continuing to increase in both prevalence and mortality. 
The second Korean National Health and Nutrition Survey revealed that the prevalence of COPD in Korean subjects 
aged ≥45 years was 17.2% in 2001. Further surveys on the prevalence of COPD were not available until 2007. 
Here, we report the prevalence of spirometrically detected COPD in Korea, using data from the fourth Korean 
National Health and Nutrition Survey (KNHANES IV) which was conducted in 2007∼2009.
Methods: Based on the Korean Statistical Office census that used nationwide stratified random sampling, 10,523 
subjects aged ≥40 years underwent spirometry. Place of residence, levels of education, income, and smoking 
status, as well as other results from a COPD survey questionnaire were also assessed.
Results: The prevalence of COPD (defined as forced expiratory volume in 1 sec/forced vital capacity ＜0.7 in 
subjects aged ≥40 years) was 12.9% (men, 18.7%; women, 7.5%). In total, 96.5% of patients with COPD had 
mild-to-moderate disease; only 2.5% had been diagnosed by physicians, and only 1.7% had been treated. The 
independent risk factors for COPD were smoking, advanced age, and male gender.
Conclusion: The prevalence of COPD was 12.9% in the KNHANES IV data. Most patients with COPD were 
undiagnosed and untreated. Based on these results, a strategy for early COPD intervention is warranted in high 
risk subjects.
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Introduction
  Chronic obstructive pulmonary disease (COPD) is a 
major disease which is continuing to increase in preva-
lence and mortality rate, worldwide1-5. In Korea, COPD 
ranked 6th among the causes of death in 20086. 
Moreover, the hospitalization cost associated with 
COPD increased from 111 billion won in 2004 to 266 
billion won in 2008. Therefore, COPD imposes a great 
burden on the public health7.
  The worldwide prevalence of COPD has been esti-
mated to be 7.5∼10%8. In a nationwide COPD preva-
lence survey in Korea in conjunction with the second 
South Korean National Health and Nutrition Examina-
tion Survey (Korean NHANES II) conducted 2001, 17.2% 
of Korean adults over the age of 45 years had COPD9. 
However, there was no follow-up survey until 2007. 
The Korean Academy of Tuberculosis and Respiratory 
Diseases and the Korea Center for Disease Control and 
Prevention conducted a survey on national health and 
nutrition, including assessment of COPD prevalence, be-
ginning in 2007. Here, we report on the prevalence of 
COPD in Korea, using data from the fourth Korean 
National Health and Nutrition Examination Survey 
(KNHANES IV).
Materials and Methods
1. Subjects
  Unlike previous surveys as short-term ones for 2∼3 
months at an interval of three years, KNHANES IV (2007
∼2009) was performed as a survey all year around. 
The KNHANES IV used rolling sampling survey method 
for the sample in each year to present the whole nation 
and to be similar by years.
  KNHANES IV investigated 4,600 households from 200 
enumeration districts per year (23 households per enu-
meration district) with the data of Population and 
Housing Census conducted by Statistics Korea as a tool 
for sampling. Enumeration districts were obtained by 
classifying the whole nation into 11 regions (seven met-
ropolitan cities; Gyeonggi, Gyeongsang/Gangwon, Chung-
cheong, Jeolla/Jeju) and they were stratified into 29 re-
gional layers by considering the population composition 
by age in Dong, Eup and Myeon of each region. After 
allocating the number of Dong, Eup and Myeon in pro-
portion to the number of enumeration districts of the 
population in each layer, 200 Dong, Eup and Myeon 
were selected in total. By reflecting characteristics of the 
selected Dong, Eup and Myeon by housing types, enu-
meration districts were extracted one by one and 23 
households were done from one enumeration district 
through systematic sampling10.
  The survey was conducted in four enumeration dis-
tricts every week or in 200 enumeration districts every 
year. The eligible subjects of KNHANES were persons 
aged over one year. Spirometry was performed for the 
subjects aged over 19 years.
2. Spirometry
  Spirometry was conducted with Dry Rolling-seal spi-
rometry (Vmax series Sensor Medics 2130; Sensor Medics, 
Anaheim, CA, USA) by specially trained technicians 
who conformed to pulmonary function test (PFT) guide-
line of American Thoracic Society and European Respi-
ratory Society11. We used the prediction equation de-
rived from the KNHANES II12.
  The results of spirometry in each enumeration dis-
tricts were transmitted to the central quality control cen-
ter through the Internet to investigate whether the re-
sults satisfied acceptability and reproducibility criteria of 
spirometry for quality control and quality assurance. 
The results finally confirmed by the principal inves-
tigator were stored in the data management system of 
Korea Centers for Disease Control and Prevention 
(KCDC).
3. Questionnaire for COPD
  Trained interviewers administered questionnaire about 
COPD at the time of spirometry. The questionnaire in-
cluded questions about whether to have history of 
COPD, whether to be diagnosed by a physician, wheth-
er to be currently treated and whether to utilize cur-
rently medical service10.
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4. Definition of COPD
  As KNHANES IV did not contain bronchodilator test-
ing, the prevalence of COPD was calculated with pre-
bronchodilator forced expiratory volume in one second 
(FEV1)/forced vital capacity (FVC). The participants 
aged over 40 years recording less than 0.7 of FEV1/FVC 
were defined to have COPD. The severity of COPD was 
determined with GOLD classification13. For analysis on 
results of spirometry, only results showing two or more 
acceptable curves and meeting reproducibility criteria 
were used11.
5. Other definition
  1) Smoking status: Non-smokers and smokers were 
defined as persons having smoked less than 100 and 
100 or more than 100 cigarettes in a lifetime, respectively. 
Out of the smokers, persons smoking and not doing at 
the time of the survey were done as current smokers 
and former smokers, respectively.
  2) Residence and income level: Persons in Eup and 
Myeon as enumeration districts were considered to live 
in rural area and those in Dong were done in urban 
area. Income level was divided based on equivalent in-
come (=monthly income/  ) by 
revising monthly income per household with the num-
ber of family members. In addition, because the income 
level was largely different by gender and age, the in-
come level was classified in a participant's own gender 
and age group. The equivalent income by gender and 
age of less than lower 25% and three upper 25% were 
defined as 'low', 'low-middle', 'middle-high' and 'high', 
respectively in the order.
6. Statistical analysis
  Statistical analysis was performed with SURVEY PRO-
CEDURE of SAS version 9.1.3 (SAS Institute Inc., Cary, 
NC, USA) reflecting sample design and weight. The 
prevalence of COPD and relevant risk factors were ana-
lyzed with SURVEYFREQ Procedure and SURVEYLO-
GISTIC Procedure, respectively. The weight of spi-
rometry was attached only to the data satisfying the suit-
ability and the reproducibility criteria of spirometry and 
it was calculated by considering sampling rate, response 
rate and population structure.
Results
  Among subjects aged over one year around the na-
tion, 23,632 participated in KNHANES IV. The partic-
ipants aged over 40 years were 11,628 and they con-
sisted of 4,936 males and 6,692 females. Out of the par-
ticipants aged over 40 years, 90.5% (10,523) took 
spirometry. Of these 10,523 subjects, 6,934 (65.9%) sat-
isfied the acceptability and reproducibility criteria. 
Among them satisfying the conditions of the test, 22.6%, 
21.7% and 55.7% were current smokers, former smokers 
and non-smokers, respectively. For males the current 
smokers, former smokers and non-smokers accounted 
for 41.2%, 41.9% and 16.9% and for females they did 
for 5.5%, 3.0% and 91.4%, respectively.
1. Prevalence of COPD
  The prevalence of COPD in KNHANES IV was 12.9% 
(male, 18.7%; female, 7.5%; Table 1). The prevalence 
of the elderly aged over 65 years recorded 28.6% (male 
46.6%, female 16.3%) and the prevalence became high-
er at older age by recording 4.3%, 10.1%, 19.9% and 
32.0% in the participants in their 40s, 50s, 60s and 70s, 
respectively (Figure 1). A total 96.5% of subjects diag-
nosed with COPD were found to have relatively mild 
disease with GOLD stage 1 and 2 (Figure 2).
  Only 2.5% of the participants found to have COPD 
had been diagnosed by physicians. Even in subjects 
with GOLD stage 3 and 4 only 15.0% had been diag-
nosed by physician (Table 2).
2. Risk factors of COPD
  According to univariate analysis on risk factors of 
COPD, old age, male, residence of rural area (Eup and 
Myeon) and history of smoking increased the risk of 
COPD while the income level of 'high' and higher edu-
cational status decreased it. Multivariate analysis with 
these variables revealed that male, old age and history 
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Table 1. Prevalence of airflow obstruction stratified by residence, education, and income
Total Male Female
No. of subjects Prevalence (%) No. of subjects Prevalence (%) No. of subjects Prevalence (%)
Age, yr
  ≥40 6,934 12.9 2,979 18.7 3,955 7.5
  ≥65 1,920 28.6 789 46.6 1,131 16.3
Residence
  Rural (Eup, Myeon) 2,098 17.4 929 25.3 1,169 9.6
  Urban (Dong) 4,836 11.6 2,050 16.7 2,786 6.9
Education
  Elementary school or less 2,642 19.5 764 34.7 1,878 12.3
  Middle school 1,160 15.2 554 24.4 606 5.5
  High school 1,908 7.3 886 12.1 1,022 2.5
  College or more 1,191 7.6 756 9.4 435 3.7
Income  
  Low 1,612 14.3 674 21.1 938 8.4
  Low∼middle 1,682 12.9 716 19.3 966 6.7
  Middle∼high 1,718 11.8 755 17.4 963 6.5
  High 1,765 10.5 768 14.8 997 6.6
Table 2. Awareness of COPD
Total GOLD 1 GOLD 2 GOLD 3 & 4
Diagnosed by physician, % 2.5 1.8 2.4 15.0
Currently treated, % 1.7 1.2 1.4 11.3
Age at diagnosis of COPD, yr* 51.4 58.5 48.5 41.4
*Data are represented as mean value. 
GOLD: global initiative for chronic obstructive lung disease; COPD: chronic obstructive pulmonary disease.
Figure 1. Prevalence of airflow obstruction stratified by 
age group.
Figure 2. Distribution of COPD severity stratified by the 
GOLD classification. COPD: chronic obstructive pulmo-
nary disease; GOLD: global initiative for chronic ob-
structive lung disease.of smoking were risk factors of COPD and higher edu-
cational status declined its risk. However, income level 
was not related with its risk (Table 3).
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Table 3. Risk factor analysis for COPD by multiple logistic regression analysis
n %
Univariate analysis Multivariate analysis
OR p-value 95% CI OR p-value 95% CI
Age, yr
  ＜65 5,014 8.1 Reference - - Reference - -
  ≥65 1,920 28.6 4.57 0.000 3.82∼5.48 4.37 0.000 3.48∼5.50
Gender
  Female 3,955 7.5 Reference - - Reference - -
  Male 2,979 18.7 2.84 0.000 2.32∼3.47 2.83 0.000 2.03∼3.92
Residence
  Urban 4,836 11.6 Reference - - Reference - -
  Rural 2,098 17.4 1.61 0.000 1.30∼1.98 1.06 0.605 0.86∼1.31
Education
  Elementary or less 2,642 19.5 Reference - - Reference - -
  Middle school 1,160 15.2 0.74 0.013 0.59∼0.94 0.83 0.185 0.62∼1.10
  High school 1,908 7.3 0.33 0.000 0.26∼0.42 0.41 0.000 0.30∼0.55
  College or more 1,191 7.6 0.34 0.000 0.25∼0.46 0.36 0.000 0.25∼0.54
Income
  Low 1,612 14.3 Reference - - Reference - -
  Low∼middle 1,682 12.9 0.88 0.323 0.69∼1.13 0.89 0.407 0.69∼1.16
  Middle∼high 1,718 11.8 0.80 0.082 0.62∼1.03 0.90 0.462 0.67∼1.20
  High 1,765 10.5 0.70 0.006 0.54∼0.90 0.90 0.472 0.67∼1.20
Smoking
  Never 4,146 7.5 Reference - - Reference - -
  Former 1,409 19.5 2.99 0.000 2.37∼3.76 1.71 0.002 1.22∼2.39
  Current 1,339 19.3 2.95 0.000 2.38∼3.67 2.33 0.000 1.70∼3.19
COPD: chronic obstructive pulmonary disease; OR: odd ratio; CI: confidence interval.
Discussion
  The prevalence of COPD of adults aged over 40 years 
recorded 12.9% in KNHANES IV. It differed from that 
of KNHANES II which was 17.2%. The discrepancy be-
tween KNHANES II and IV was considered to be caused 
by different criteria of spirometry rather than actual dif-
ference in the prevalence. While KNHANES II utilized 
the results of spirometry showing two or more accept-
able curves to calculate the prevalence, KNHANES IV 
used the reproducibility criteria in addition to accept-
able criteria. When the prevalence of COPD was calcu-
lated by applying the criteria of KNHANES II using the 
data in the second year of KNHANES IV it recorded 
17.7%14 so that the prevalence of COPD was not sig-
nificantly different between KNHANES II and IV.
  In KNHANES IV, the prevalence of COPD of males 
was two times higher than that of females by recording 
18.7% and 7.5%, respectively and the prevalence be-
came higher at older age. In addition, the prevalence 
of smokers was higher than that of non-smokers. Multi-
variate analysis found that male, old age and history of 
smoking were statistically significant risk factors of 
COPD. Although low income level had been observed 
to be an independent risk factor in KNHANES II, it was 
not related with COPD in KNHANES IV. Instead, the 
subjects with higher educational background showed a 
lower risk of COPD than those with lower one.
  Despite relatively high prevalence of COPD, its diag-
nosis rate is very low15 and even patients actually treat-
ed for COPD do not know their diagnosis name accu-
rately in many cases16. This study also revealed that on-
ly 2.5% of the subjects with COPD were diagnosed as 
COPD. Even in subjects with GOLD 3 and 4, only 15.0% 
had been diagnosed by physicians and only 75.6% 
(N=6) out of them were currently treated. So, efforts to 
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Table 4. Prevalence of COPD using the LLN
Prevalence (%)
Total Male Female
Age, yr
  ≥40 10.3 12.8 8.0
  ≥65 14.6 22.8 9.1
  40∼49 8.0 8.0 8.0
  50∼59 9.2 11.8 6.6
  60∼69 12.5 18.5 7.2
  ≥70 15.7 23.5 10.9
COPD: chronic obstructive pulmonary disease; LLN: lower limit
of normal.
raise the awareness of COPD are needed in the future.
  Although many treatments for COPD such as smoking 
cessation, medication, pulmonary rehabilitation and 
oxygen therapy have been utilized, there has been no 
medication slowing the rate of declining pulmonary 
function or reducing the mortality rate up to now. 
However, recent large-scale researches have reported 
that some medications can decrease the rate of declin-
ing of lung function and the mortality rate17-19 in patients 
with moderate COPD, so that the importance of early 
detection of and proper treatments for COPD has been 
increased. This study found that 60.5% and 36.0% of 
the patients diagnosed as COPD recorded GOLD stage 
1 and 2, respectively. Only 2.4% of those recording 
GOLD stage 2 had been diagnosed by physicians and 
only 1.4% of them were currently treated. For GOLD 
stage 1, the rates of being diagnosed by physicians and 
being treated were lower by recording 1.8% and 1.2%, 
respectively. This finding showed again the importance 
of early detection and early treatment. Until now a uni-
form screening test using spirometry for early detection 
of COPD has not been recommended20, but the neces-
sity of screening test for early detection for subjects with 
risk factors of COPD has been suggested21. Because 
KNHANES IV revealed that the diagnosis rate of COPD 
was very low and its risk factors including history of 
smoking were determined, this result supported the ne-
cessity of screening test for high-risk group of COPD.
  Although KNHANES IV minimized seasonal and re-
gional bias by investigating all year around, secured the 
representativeness of results by attaching the weight 
through post-hoc adjustment and could obtain more ac-
curate prevalence of COPD by applying stricter accept-
ability and reproducibility criteria, it had some limita-
tions. First, it did not exclude other diseases associated 
with airflow obstruction such as bronchiectasis and tu-
berculous destroyed lung because it did not utilize chest 
radiography. Second, the existence of airflow obstruc-
tion was evaluated with a fixed ratio using FEV1/FVC 
＜0.7, so that the prevalence of the elderly could be 
overestimated. Moreover, it could not exclude com-
pletely the possibility of including asthma and other dis-
ease because bronchodilator testing was not conducted.
  When COPD was diagnosed with a fixed ratio of 
FEV1/FVC, the possibility of overestimation among the 
elderly and underestimation among the young has been 
raised continuously. To minimize it, lower limit of nor-
mal has been recommended13,22. The prevalence of 
COPD calculated with lower limit of normal was 10.3% 
(Table 4).
  To supplement these limitations, KNHANES V apply-
ing stricter spirometry criteria of showing three accept-
able curves and meeting reproducibility criteria is in 
progress. It also includes bronchodilator testing and is 
planned to use both of a fixed ratio and lower limit of 
normal to obtain the prevalence of COPD.
  In summary, the prevalence of COPD among Korean 
adults aged over 40 years was 12.9% in KNHANES IV 
and 96.5% of the participants with COPD were GOLD 
stage 1 and 2. Most COPD patients had not been diag-
nosed by physicians and consequently had not been 
treated appropriately. Early management for subjects 
with risk factors of COPD is considered to be necessary, 
and currently ongoing KNHANES V is expected to ob-
tain more accurate prevalence of COPD.
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